中财网 中财网股票行情
新华制药(000756)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)673416.62473248.15247469.75810084.47649753.48
营业收入(万元)673416.62473248.15247469.75810084.47649753.48
营业总成本(万元)633708.94441419.39232885.90753090.48603925.78
营业成本(万元)515191.34354793.18179572.97570914.24460740.77
净利润(万元)41930.3429300.5214268.6849800.3541583.92
归属于母公司的净利润(万元)34408.0026540.4414187.9449651.2239196.84
营业利润(万元)39827.0430757.0017055.7053458.2044687.02
利润总额(万元)39291.7630336.3816877.1553268.5744647.68
少数股东损益(万元)1136.93736.19338.47959.48832.14
基本每股收益(元)0.50(元)0.39(元)0.21(元)0.74(元)0.58(元)
稀释每股收益(元)0.50(元)0.38(元)0.21(元)0.72(元)0.57(元)
非经常性损益(万元)----415.20----
扣除非经常性损益后净利润(万元)32141.1524936.6413772.7546153.5436272.19
总资产(万元)882437.29873385.91846797.74828616.63792181.71
总负债(万元)372836.54375921.16347701.68351041.30322070.93
归属于母公司股东权益合计(万元)487140.70475406.59476491.86455310.39447937.47
股东权益合计(万元)509600.75497464.76499096.06477575.33470110.78
实收资本(股本)(万元)68240.7668240.7668240.7667468.2867468.28
资本公积(万元)113106.20112273.20111440.19105501.09106173.52
未分配利润(万元)246185.67240024.14244731.83230543.89224508.61
经营活动产生的现金流量净额(万元)25424.077740.113806.3426527.897624.52
经营活动现金流入小计(万元)600561.99412981.48203879.46705719.13553071.37
经营活动现金流出小计(万元)575137.93405241.37200073.12679191.24545446.86
投资活动产生的现金流量净额(万元)-14077.56-9662.81-5247.53-30510.86-18043.23
投资活动现金流入小计(万元)891.1751.854.612002.472016.27
投资活动现金流出小计(万元)14968.739714.665252.1432513.3320059.50
筹资活动产生的现金流量净额(万元)13515.167665.701678.88-19610.96-20793.35
筹资活动现金流入小计(万元)95909.3465954.3616355.2786844.7283351.65
筹资活动现金流出小计(万元)82394.1958288.6614676.39106455.68104144.99
期末现金及现金等价物余额(万元)104298.5485092.1778824.6978168.4370172.31
最后修改日期2024-10-302024-08-222024-04-262024-03-282023-10-27
↑返回页顶↑

转至新华制药（000756）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。